On April 9, 2024, Antibe Therapeutics Inc. ("Antibe" or the "Company"), initiated proceedings (the "CCAA Proceedings") under the Companies' Creditors Arrangements Act (“CCAA").

On the same day, the Ontario Superior Court of Justice (the “Court") granted an Initial Order which, among other things: (i) granted a stay of proceedings up to and including April 18, 2024; and (ii) appointed Deloitte Restructuring Inc. as Court-appointed monitor of the business and financial affairs of Antibe (in such capacity, the “Monitor").  

Pursuant to the Order of the Honourable Justice Osborne (Commercial List) issued on April 30, 2024, FTI Consulting Canada Inc. was appointed as receiver and manager, without security, of the assets, undertakings and properties of Antibe Therapeutics Inc., effective April 22, 2024.

If you have any questions regarding this matter, please contact FTI Consulting Canada Inc. at the following:

Toll-Free Number: 1-833-511-7227

Local Number: 416-649-8082

Email: antibe@fticonsulting.com